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The ability to analyze and understand the mechanisms by which cells process information is a
key question of systems biology research. Such mechanisms critically depend on reversible
phosphorylation of cellular proteins, a process that is catalyzed by protein kinases and
phosphatases. Here, we present PhosphoPep, a database containing more than 10000 unique
high-conﬁdence phosphorylation sites mapping to nearly 3500 gene models and 4600 distinct
phosphoproteins of the Drosophila melanogaster Kc167 cell line. This constitutes the most
comprehensive phosphorylation map of any single source to date. To enhance the utility of
PhosphoPep, we also provide an array of software tools that allow users to browse through
phosphorylation sites on single proteins or pathways, to easily integrate the data with other,
external data types such as protein–protein interactions and to search the database via spectral
matching. Finally, all data can be readily exported, for example, for targeted proteomics approaches
and the data thus generatedcan be again validated using PhosphoPep, supporting iterativecycles of
experimentation and analysis that are typical for systems biology research.
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Introduction
It is the premise of systems biology that biological processes
are studied as integrated systems consisting of multiple inter-
acting elements and that the basis for the system’s properties
is the contextual information of the elements interactions.
Operationally, biological systems are frequently represented
as networks and their properties are studied by iterative cycles
of targeted network perturbation followed by quantitative
measurement of all the system’s elements (Ideker et al, 2001).
Networks typically studied are transcriptional networks
analyzed by gene expression arrays (Schena et al, 1995;
Lipshutz et al, 1999) and CHIPon chip assays (Ren et al, 2000;
Iyer et al, 2001), protein interaction networks analyzed by the
yeast two-hybrid systems (Fields and Song, 1989; Uetz et al,
2000; Giot et al, 2003) ormass spectrometryof puriﬁedprotein
complexes (Rigaut et al, 1999; Gavin et al, 2002; Gingras et al,
2005; Ewing et al, 2007) and genetic interactions analyzed by
synthetic lethal screens (Tong et al, 2001). Protein phosphory-
lation, a network of protein kinases and phosphatases and
their respective cellular substrates, is a universal regulatory
mechanism and plays a pivotal role in the control of most
cellular process.Thus,the understanding of protein phosphor-
ylation networks and their dynamic changes is of fundamental
importance for systems biology (Hunter, 2000).
Recently, phosphoproteomics has become a robust tech-
nique for the analysis of protein phosphorylation networks.
Typically, (phospho)protein samples are digested with a
protease, and the peptides are analyzed by liquid-chromato-
graphy tandem mass spectrometry (LC-MS/MS) (Aebersold
and Mann, 2003). As after the digestion of a proteome phos-
phopeptides are present at a low concentration, it is necessary
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Goodlett,2001;ReindersandSickmann,2005).Recently,several
phosphopeptide enrichment methods have been described
and their performance has been compared (Bodenmiller et al,
2007a). They include afﬁnity chromatography and phosphor-
amidate chemistry-based puriﬁcation. The most commonly
used afﬁnity-based methods are immobilized metal afﬁnity
chromatography (IMAC) (Andersson and Porath, 1986) and
titanium dioxide (TiO2) (Pinkse et al, 2004; Larsen et al, 2005).
As an alternative phosphoramidate chemistry (PAC), in which
the phosphopeptides are covalently captured on an amino-
modiﬁed solid phase (e.g. a dendrimer (Tao et al, 2005) orglass
beads (Zhou et al, 2001; Bodenmiller et al,2 0 0 7 b ) )a n da r e
released by acid hydrolysis of the phosphoramidate bond
(Zhou et al, 2001; Tao et al, 2005; Bodenmiller et al, 2007a,b)
can be used.
Using the technologies described above, several large
scale data sets on protein phosphorylation have recently
been published (Ficarro et al, 2002; Beausoleil et al, 2004;
Schwartz and Gygi, 2005; Olsen et al, 2006). However, a
numberoffactorslimittheusefulness ofthesedataforsystems
biology research. First, the data sets are far from being
complete. Second, false-positive and false-negative error rates
are frequently unknown and spectra may not be accessible to
independently assess the quality of peptide identiﬁcation and
assigned site of phosphorylation. Third, the data are mostly
presented as lists of identiﬁed phosphopeptides, limiting their
use for further experimentation or meta-analysis.
In this report, we describe PhosphoPep, a database
for phosphopeptides and phosphoproteins from Drosophila
melanogaster Kc167 cells and a suite of associated software
tools as a resource for systems biology research in D. melano-
gaster. The small genome size, short generation time, the
highly developed genetic tools that can be easily combined
with biochemical analysis (Bier, 2005) and the high degree of
conservation of signaling pathways between the ﬂy and
humans (Reiter et al, 2001) make Drosophila an ideal, but as
yet largely unexplored species for systems biology. Phospho-
Pep contains over 10000 high-conﬁdence phosphorylation
sites from 3472 gene models and 4583 distinct phosphopro-
teins, and therefore, is the as yet most completely mapped
phosphoproteome of any single source.
To support further experimentation and analysis of the
phosphorylation data,weaddedtothePhosphoPep databasea
number of software tools. First, we implemented a search
function to detect the sites of phosphorylation on individual
proteins and to place phosphoproteins within cellular
pathways as deﬁned by the Kyoto Encyclopedia of Genes and
Genomes (KEGG) pathway database (Kanehisa et al, 2006).
Such pathways, along with the identiﬁed phosphoproteins
can be interrogated by a pathway viewer and exported to
Cytoscape (Shannon et al, 2003), a software tool, which
supports the integration of the data from PhosphoPep and
other databases. Second, we added utilities for the use of the
phosphopeptidedatafortargetedproteomicsexperiments.Ina
typical experiment of this type, the known phosphorylation
sites of a protein or set of proteins are detected and quanti-
ﬁed in extracts representing different cellular conditions via
targetedmassspectrometryexperimentssuchasMRM(Gerber
et al, 2003; Domon and Aebersold, 2006; Picotti et al, 2007;
Stahl-Zengetal,2007;Wolf-Yadlinetal,2007).Third,wemade
the data in PhosphoPep searchable by spectral matching
through SpectraST (Lam et al, 2007). Speciﬁcally, for each
distinct phosphopeptide ion identiﬁed in this study, all corres-
ponding MS2 spectra were collapsed into a single consensus
spectrum. Unknown query spectra can then be identiﬁed by
spectral searching against the library of phosphopeptide
consensus spectra.
Collectively, PhosphoPep and the associated software tools
and data mining utilities support the use of the data for diverse
types of studies, from the analysis of the state of phosphory-
lation of a single protein to the detection of quantitative
changes in the state of phosphorylation of whole signaling
pathways at different cellular states and has been designed to
enabletheiterativecyclesofexperimentationandanalysisthat
are typical for systems biology research.
Results and discussion
Strategy
To generate an extensive phosphopeptide map of D. melanoga-
ster KC 167 cells, we ﬁrst performed a large-scale phosphory-
lation site mapping project as described in the Supplementary
information and Supplementary Figure S1. Brieﬂy, as the
phosphoproteome strongly depends on the cellular state, we
performed tryptic digestion of protein extracts from D. melano-
gaster Kc167 cells grown under various conditions: nutrient-rich
medium; nutrient-depleted medium; medium supplemented
with insulin (a growth inducer); medium supplemented with
rapamycin (a growth inhibitor); and medium containing
Calyculin A, an inhibitor of protein phosphatase 1 and protein
phosphatase 2A. The combined peptide sample was separated
by peptide isoelectric focusing (IEF) in a free-ﬂow electrophor-
esis (FFE) instrument (Malmstrom et al, 2006). From each
fraction phosphopeptides were isolated using three different
phosphopeptide isolation methods (IMAC, TiO2 and PAC) to
maximize coverage of the phosphoproteome (Bodenmiller et al,
2007a). Each phosphopeptide fraction was then subjected to LC-
MS/MS using a high mass accuracy tandem mass spectrometer.
The generated LC-MS/MS data were searched against a protein
(decoy) database and the identiﬁed phosphorylation sites were
validated using the PeptideProphet software tool (Keller et al,
2002) or the target-decoy search strategy (Elias and Gygi, 2007).
The resulting combined data set consisting of 10118 high-
conﬁdence phosphorylation sites from 3472 gene models and
4583 distinct phosphoproteins was incorporated into the
PhosphoPep database.
Assignment of fragment ion spectra to
phosphopeptide sequences
The fragment ion spectra obtained in this study were assigned
to (phospho)peptide sequences using the sequence database
search tool Sequest (Eng et al, 1994) and were investigated for
twoformsoferrorsinthedataset:ﬁrst,themiss-assignmentof
the fragment ion spectrum to a peptide sequence (Keller et al,
2002; Elias and Gygi, 2007) and second, the miss-assignment
of the phospho-amino acid in an otherwise correctly identiﬁed
phosphopeptide (Beausoleil et al, 2006).
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tool PeptideProphet (Keller et al, 2002) or a decoy database
(DD) (Elias and Gygi,2007), wefound that ata PeptideProphet
probability score cut off value of 0.8 approximately 2.6%
(1.8% DD), at a cut off of 0.91.5% (0.8% DD) and at a cut off
of 0.99 approximately 0.2% (0% DD) of all identiﬁcations
were false-positive assignments. Based on these results, we
decided to upload all phosphopeptides with a PeptideProphet
probability score greater than 0.8 into PhosphoPep.
To assess the second type of error, the miss-assignment of
the phospho-amino acid in a correctly identiﬁed phosphopep-
tide we used the dCn score computed by Sequest (Eng et al,
1994) as described in the Supplementary information and
Supplementary Figure S2. We found that a dCn value greater
than 0.1 corresponds to 490% certainty in phosphorylation
site assignment. Overall, the application of a dCn threshold of
0.1 yielded 10118 distinct phosphorylation sites (PeptidePro-
phet probability score 40.9) or 12756 phosphorylation sites
(PeptideProphet probability score 40.8). Without any dCn
ﬁlter PhosphoPep contains 12596 (PeptideProphet probability
score 40.9) or 16608 phosphorylation sites (PeptideProphet
probability score 40.8).
Structural and functional properties of the
identiﬁed phosphopeptides
We next analyzed the structural and functional properties,
namely the distribution and number of phosphorylated residues
per phosphopeptide, the molecular functions, and the biological
processesandthepathwaysthatareassociatedwiththeidentiﬁed
phosphoproteins along with their predicted abundance.
Distribution of phosphorylated amino acids
We found that 78% of the identiﬁed phospho-amino acids
were phosphorylated on a serine, 19% on a threonine and 3%
on a tyrosine. Furthermore, nearly 87% of all peptides were
phosphorylated at one site, 10% at two sites and 3% at three
sites. These results are slightly different from the so far
assumed distribution of phospho-amino acids (Hunter and
Sefton, 1980) (89% serine, 10% threonine and 1% tyrosine)
and other large-scale data sets (Olsen et al, 2006).
Molecular function and biological processes
To derive the molecular functions and biological processes of
the identiﬁed phosphoproteins, we used ‘panther’ ontology
(PO) (Mi et al, 2007). We also investigated whether some
molecular functions or biological processes were enriched
or depleted in the phosphoprotein data set compared to an
external(proteomepredictedfromtheFlyBase(r4.3)sequence
database) and an internal reference (proteins identiﬁed from
the peptide sample before the phosphopeptide enrichment).
For both the molecular function (Figure 1A) and the
biological processes (Figure 1B), all possible PO annotations
wereidentiﬁedfromthephosphoproteindataset.However,for
many processes and functions, biases were visible compared
to the external reference. Many of these biases can be explai-
ned by proteomics workﬂows, in which low-abundant, small
or membrane proteins are often underrepresented (Brunner
et al, 2007). This is also reﬂected in the comparison between
the internal and external reference. We therefore also contras-
ted the phosphoprotein data set to the internal reference
detecting differences between the two proteomic data sets
(Figure 1A and B).
In regards to the molecular functions and biological
processes, enrichment for phosphoproteins (compared to the
internal reference) involved in regulatory processes was
apparent, in particular for kinases, transcription factors, ion
channels (Figure 1A) or developmental processes (Figure 1B).
In contrast, in the categories metabolism (lyases, isomerases
and synthases) or metabolic processes (sulfur, coenzyme,
carbohydrate and other metabolism) phosphoproteins were
depleted (Figure 1B). The overrepresentation of kinases,
transcription factors and ion channels compared to the inter-
nalreferenceisexpectedastheseclassesofproteinsareknown
to be highly regulated by protein phosphorylation (Hunter,
2000). In addition, the enrichment of phosphoproteins in
developmental processes indicates that these processes are
highly regulated by protein phosphorylation as well.
Pathway association and abundance of identiﬁed
phosphoproteins
We next investigated the depth of phosphoproteome coverage
achieved by the data set. Of 118 PO pathways (Mi et al, 2007)
(from the FlyBase database (r4.3) (Grumbling and Strelets,
2006)) 98 were represented by the phosphoproteome data set.
Most of the pathways to which no phosphoprotein could be
assigned (15 of the 20) consisted of equal to or less then three
proteins, thus reducing the likelihood of their detection.
A comparison of the codon bias distribution (Duret and
Mouchiroud, 1999) of the complete predicted D. melanogaster
proteome (from the FlyBase database (r4.3)) with that of the
identiﬁed phosphoproteins showed similar curves, indicating
that proteins from all levels of abundance were identiﬁed
(Figure 1C). Overall, these data indicate that the phospho-
protein data set reached a considerable depth of the analysis
of the phosphoproteome of Kc167 cells. This ﬁnding is further
strengthened by the observation that we detected proteins
mapping to over 50% of so far B6200 gene models in
D.melanogasterKc167cellsforwhichaproteinwasdetectable
(Brunner et al, 2007).
For systems biology-based signaling research, such an in-
depth coverage of phosphorylation sites is highly beneﬁcial
and strengthens the use of D. melanogaster Kc167 cells as a
model organism for systems biology.
PhosphoPep—a database and associated utilities
for systems biology signaling research
Toincreasetheutilityofthephosphopeptidedatasetdescribed
above,weorganizedthedatainapubliclyaccessiblerelational
database, PhosphoPep, and added functions supporting data
mining and meta-analysis. The following sections describe the
database and the added functions.
The PhosphoPep database
The consolidated D. melanogaster Kc167 cell phosphopeptide
data set was uploaded to PhosphoPep, which is publicly
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Figure 1 Phosphoprotein properties. (A) Depletion/enrichment of molecular functions derived from ‘panther’ ontology (Mi et al, 2007) of the corresponding
phosphoproteins (red) andthe proteins identiﬁed fromthe separated peptides before enrichment (yellow) relative tothe FlyBase database (0%) isshown. (B)Depletion/
enrichment of biological functions derived from ‘panther’ ontology (Mi et al, 2007) of the corresponding phosphoproteins (red) and the proteins identiﬁed from the
separated peptides before enrichment (yellow) compared to the FlyBase database (0%) is shown. (C) A comparison of the predicted phosphoprotein abundance (blue)
with the predicted abundance (Duret andMouchiroud, 1999) of all proteins of the usedFlyBase database (pink) is shown. The scale ranges from 0 (low abundance) to 1
(highlyabundant). Proteinsforwhichno molecular functionorbiological process couldbe assignedwere omittedfor (A)and(B).w
2 testresultsfor (A)and(B)are shown
in Supplementary Table II.
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vative of the UniPep (Zhang et al, 2006) and PeptideAtlas
(Desiere et al, 2005) databases, connected to the Systems
Biology Experiment Analysis Management System (SBEAMS;
http://www.sbeams.org), a tool to collect, store and access
differentdatatypes.Allpeptideswereparsedandloadedintoa
relational database using SQL (structured query language).
Access to the phosphorylation sites and the database is
provided by a cgi web interface.
We designed a ‘Search interface’ that allows users to query
the data using different parameters (Figure 2A). These include
searches for single proteins (using the gene ID, protein name,
gene symbol, swiss-prot/FlyBase accession number or amino-
acid sequence) or searches for a set of proteins (identiﬁed
proteins search, bulk search and pathway search) at a user-
deﬁned PeptideProphet probability score. When a search is
executed, a list of all proteins that match the search criteria is
shown.Eachlistingcontainsalinktoviewadetailedrecordfor
the respective phosphoprotein entry, called ‘protein informa-
tion page’. On that page for each protein in the PhosphoPep
database, four different types of information (Figure 2B) are
displayed.
The ﬁrst section, ‘Protein info,’ indicates the protein
database ID, the protein name (including synonyms), and a
protein summary. The ‘Protein info’ section also contains
three links represented by symbols. The ﬁrst link queries the
protein sequence for potential kinase motives using the
Scansite (Obenauer et al, 2003) algorithm. The second
link displays all KEGG pathways in which the respective
phosphoprotein is represented and the third link allows
exporting the phosphoprotein to the Cytoscape software (see
‘Pathway search, pathway building and data integration’).
Additionally, the ‘Protein info’ section categorizes the sub-
cellular location of the proteins into cell surface, secreted,
transmembrane or intracellular (Nielsen et al, 1997; Krogh
et al, 2001).
The second section displaysthe‘Observed phosphopeptides’.
Foreveryprotein,allphosphopeptidesidentiﬁedinthedataset
are shown. To allow the user to assess the quality of the
phosphopeptide assignment, the PeptideProphet (Keller et al,
2002) score is given as well as the number of tryptic ends, the
mass of the phosphopeptide, the dCn value (Eng et al, 1994),
a link to the MS2 consensus spectrum and a link to export
the consensus spectrum ion values for targeted proteomic
approaches (See consensus spectrasection below). In addition
unambiguouslyassignedphosphorylationsites(dCn40.1)are
highlighted in red and ambiguous sites (dCno0.1) are
highlighted in yellow. Finally, for each phosphopeptide, it is
indicated if it maps to a single protein or to several, an
important aspect for quantitative targeted proteomics experi-
ments.
In the third section, ‘Protein/Peptide sequence’, the whole
sequence of the respective phosphoprotein is shown with the
identiﬁedphosphopeptides,thesite(s) ofphosphorylation and
transmembrane regions, which are highlighted to give a
general overview.
In the forth section ‘Protein/Peptide map’, the phospho-
peptides and the phosphorylation sites are shown according
to their position in the protein sequence, thereby giving an
indication of the general protein topology.
Pathway search, pathway building and data integration
To build pathways and query the phosphorylation state of the
constituent proteins, we placed a protein or proteins contained
in PhosphoPep within pathways retrieved from KEGG (Kane-
hisa et al, 2006) (‘Pathway view’, Figure 2A). Proteins can be
placed into ‘Pathway view’f r o mb o t ht h e‘ Search interface’a s
well as from the ‘Protein information’ page of a given protein.
‘Pathway view’ also retrieves fromPhosphoPep and displays all
other identiﬁed phosphoproteins of a particular pathway. A
‘Bulk search’ option allows placing all of the proteins within
their respective pathways. Finally, each pathway can readily be
exported,annotatedwiththerelevantphosphoproteininforma-
tionto‘Cytoscape’(Shannonetal,2003).Cytoscapeisageneric
visualizationtooltointegrateandvisualizedifferentdatatypes.
In this case, the phosphoprotein information contained in
PhosphoPep can be complemented with additional data types,
such as biomolecular interaction networks, accessible through
the web. To facilitate the retrieval of relevant information,
‘Cytoscape’ is automatically linked to ‘Gaggle’ (Shannon et al,
2006). Gaggle is an informatics-working environment in which
information from different web resources can be retrieved and
imported into the Cytoscape environment.
Consensus spectra: a searchable fragment ion
representation of the phosphoproteome
The analysis of proteomic data sets carries alarge computational
overhead. This is particularly true for spectra of phosphopep-
tides, due to their particular fragmentation characteristics and
increased peptide search space in database searching. Further-
more, targeted proteomic workﬂows are emerging in which sets
of speciﬁc analytes, for example, the phosphorylation sites on
proteins constituting a signaling pathway are analyzed under
varying cellular conditions (Domon and Aebersold, 2006; Wolf-
Yadlin et al, 2007). To support the rapid (Supplementary Figure
S3A), highly sensitive (Supplementary Figure S3B and Supple-
mentary Table I) and reliable identiﬁcation of phosphopeptides
in future experiments and targeted mass spectrometry by
MRM, we built a searchable consensus spectral library of most
identiﬁed peptides in PhosphoPep, and made them available
in a searchable and downloadable form (Figure 2A).
By using the spectral matching search tool SpectraST (Lam
et al, 2007), both as a web interface in PhosphoPep, and as a
stand-alone application released as part of the TPP suite of
software (Keller et al, 2005), spectra can be searched against
the phosphopeptide consensus library (see also Supplemen-
tary information).
To support MRM-based targeted proteomic experiments, we
provide a download function for consensus spectra represent-
ing a speciﬁc phosphopeptide (Domon and Aebersold, 2006;
Picotti et al, 2007; Stahl-Zeng et al, 2007; Wolf-Yadlin et al,
2007).Suchspectracanbeausefulstartfortheoptimizationof
precursor ion to fragment ion transitions for MRM experi-
ments, for example by performing MRM-triggered MS2
experiments searchable against the phosphopeptide consen-
sus spectra library (Lam et al, 2007).
Overall, these functionalities are highly useful for research-
ers focused on single proteins and especially for systems
biologists who wish to conduct iterative cycles of experimen-
tation and analysis on differentially perturbed cell states.
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There is no ‘gold standard’ phosphoproteome data set that
could be used to assess the extent to which the Kc167
phosphoproteomehasbeenmappedout.Tofurtherinvestigate
the achieved phosphoproteome coverage, we compared the
phosphorylation sites from our data set that matched the
highly conserved (Oldham et al, 2000; Garofalo, 2002) and
clinically relevant insulin/TOR pathway with the already
known sites in D. melanogaster.
Search
interface
Protein
information  
Cytoscape
Gaggle
Consensus
spectra
Data export
for MRM
Consensus
spectra
library search
Pathway
view
α β
χ
δ
ε
φ γ
φ A
B
Identified Sequence PeptideProphet Tryptic ends Peptide mass DeltaCN No. of
Mappings
No. of
Obs
Links
Sequence position
100 200 300 400 500
445 (1)
461 (1)
100 200 300 400 500
Observed peptide: (No. of observations)
Observed phosphorylation sites
Observed peptides
Phosphorylation sites
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members,6 (dAKT1, CHICO, dFOXO,dTSC2,dS6Kand d4E-BP)
have been known to be phosphorylated in D. melanogaster.I n
our data set, we found all 15 members to be phosphorylated.
Furthermore, for the proteins for which phosphorylation sites
have been published previously, we were able to identify
multiple new sites. The most prominent example is the insulin
receptor substrate, CHICO, for which the number of known
phosphorylation sites increased from 2 to 20. For dFOXO and
d4E-BP, we identiﬁed all, and for dS6K, we identiﬁed one
already known phosphorylation sites. For dAKT1, CHICO and
dTSC2, the already known sites were not found in our
experiments, indicating that in spite of the high number of sites
identiﬁedinthisstudytheKC167phosphoproteomeislikelynot
complete at this time (see Supplementary information).
This example shows that we have reached a depth in
phosphoproteomecoveragethatissuitableforsystemsbiology
signaling research in D. melanogaster and, due to a myriad of
orthologous sites (Reiter et al, 2001), also in other species.
Materials and methods
All chemicals, if not otherwise mentioned, were bought with the
highest available purity from Sigma-Aldrich, Taufkirchen, Germany.
Cell culture, lysis and protein digestion
D. melanogaster Kc167 cells were grown in Schneiders Drosophila
medium (Invitrogen) supplemented with 10% fetal calf serum, 100U
penicillin (Invitrogen) and 100mg/ml streptomycin (Invitrogen, Auck-
land, New Zealand) in an incubatorat 251C. To increase the numberof
mapped phosphorylation sites, different batches of cells were pooled.
Cells were either grown in rich medium, or were serum-starved, or
were treated for 30min with 100nM Rapamycin (LClabs, Woburn, MA,
USA) in rich medium, or were treated for 30min with 100nM insulin
(serum starved), or were treated for 30min with 100nM Calyculin A
Figure 2 (A) Design of the PhosphoPep database. By using the ‘Search interface’( a) PhosphoPep can be interrogated for single proteins, a set of proteins or
pathways. For each protein, several types of information including the observed phosphopeptides is shown in the ‘Protein information’ page (see panel B and b.
Singleproteinsorasetofproteinscanbeplacedintotheirpathways(w).Fromthis‘Pathway view’allphosphoproteins canbeexportedtoCytoscape(Shannonetal,
2003) (d). This software tool allows integrating data from PhosphoPep with external data such as protein–protein interaction networks (e). For most phosphopeptides,
consensus MS2 spectra (f) are given which can be exported for targeted proteomics experiments such as multiple reaction monitoring (Domon and Aebersold, 2006)
(g). As we supply an online spectral matching search tool, results generated by such experiments can be validated using PhosphoPep. (B) Representative output of the
PhosphoPep database. The PhosphoPep (www.phosphopep.org) database contains more than 10000 phosphorylation sites from nearly 3500 gene models and nearly
5800 phosphoproteins derived from the FlyBase (Grumbling and Strelets, 2006) nonredundant database (r4.3). For each phosphoprotein, the phosphopeptide
sequence, the protein annotation and the predicted subcellular location is shown. Furthermore, additional information for each phosphopeptide is given: The probability,
the number of tryptic ends, the dCn value, the mass, how often it was observed and to how many gene models and transcripts it maps. The phosphopeptides are
represented in both the protein sequence and in a graphical representation, the protein map. Finally, a link to the ‘Pathway view’, to the ‘Cytoscape export’ function
and to http://scansite.mit.edu/ (Obenauer et al, 2003) is given as represented by the three symbols besides the FlyBase gene entry.
CHICO
dFOXO
dS6K
P
3
2
2 2
dInR
dPi3K dAKT1
CHICO
dPTEN
dFOXO
dTSC1
dTSC2
dRHEB
dPDK1
5
20
5
2
7
4
10
1
4
2
2
No 
sites known
Extensive 
site coverage
P P
P
P P
P
P
P
P
P
P
P
P
P
P
dInR
dAKT1 dPi3K
dPTEN
dTSC1
dTSC2
dRHEB
d4E-BP
5
dTOR
d4E-BP dS6K
dRictor
1
6
3 7
P
P
P
P
dRaptor
6
P
dTOR
1
P
dTOR
dRaptor
dRictor
dTOR
dPDK1
Figure 3 Proteins involved in the target of rapamycin (TOR) and insulin signaling. To demonstrate the usefulness of our database, we compared the already known
phosphoproteins (left) with our identiﬁed phosphoproteins (right). As can be seen, compared to the literature in which only 6 out of the 15 proteins were found to be
phosphorylated, we extended the phosphorylation map to all proteins of the pathway (Hay and Sonenberg, 2004; Oldham and Hafen, 2003) (phosphorylation sites are
depicted by the P in a red circle, the number assigns the number of distinct phosphorylation sites). The number of identiﬁed phosphorylations ranged from 1 to 20
(CHICO). Peptides with P40.8 and a deﬁned phosphorylation site (dCn>0.1) were considered.
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buffered saline and resuspended in ice-cold lysis buffer containing
10mMHEPES,pH7.9,1.5mMMgCl2,10mMKCl,0.5mMdithiothreitol
and a protease inhibitor mix (Roche, Basel, Switzerland).
To preserve protein phosphorylation, several phosphatase inhibitors
were added to a ﬁnal concentration of 20nM calyculin A, 200nM
okadaic acid, 4.8mm cypermethrin (all bought from Merck KGaA,
Darmstadt, Germany), 2mM vanadate, 10mM sodium pyrophosphate,
10mM NaFand 5mM EDTA. After 10min incubation on ice, cells were
lysed by douncing. Cell debris and nuclei were removed by centrifuga-
tionfor10minat41Cusing5500g.Thenthecytoplasmicandmembrane
fraction were separated by ultracentrifugation at 100000g for 60min at
41C. The proteins of the cytosolic fraction (supernatant) were subjected
to acetone precipitation. The protein pellets were resolubilized in 3mM
EDTA,20mMTris–HCl,pH8.3,and8Murea.Thedisulﬁdebondsofthe
proteins were reduced with tris (2-carboxyethyl) phosphine at a ﬁnal
concentration of 12.5mM at 371C for 1h. The produced free thiols were
alkylated with 40mM iodoacetamide at room temperature for 1h. The
solution was diluted with 20mM Tris–HCl (pH 8.3) to a ﬁnal
concentration of 1.0M urea and digested with sequencing-grade
modiﬁed trypsin (Promega, Madison, WI) at 20mg per mg of protein
overnight at 371C. Peptides were desalted on a C18 Sep-Pak cartridge
(Waters, Milford, MA) and dried in a speedvac. Finally, 280mg of
peptides were separated by IEF using FFE.
Peptide separation
FFE-Weber reagent basic kit (Prolyte 1, Prolyte 2, Prolyte 3 and
Prolyte 4–7 and pI markers) were purchased from FFE-Weber
Inc. (now BD-Diagnostics, NJ, USA). Hydroxyisobutyric acid, DL-2-
aminobutyric acid, nicotinamide, glycyl-glycine and ethanolamine
were purchased from Sigma-Aldrich (Steinheim, Germany), AMPSO
and HEPES from Roth (Karslruhe, Germany) and TAPS from ACROS
(NJ, USA).
Free-ﬂow electrophoresis
IEF was performed using an FFE instrument, type prometheus from
FFE Weber Inc. (now BD-Diagnostics, PAS). For a detailed description
ofthe experimental procedure, pleasesee Malmstromet al (2006). The
digested peptides were diluted in separation media containing 8M
Urea and 250mM Mannitol and 20% ProLyte solution at a concentra-
tion of 10mg/ml. This samplewas loaded continuously for 1h at 1ml/
h. Total collection time was 24h and the volume of each collected
fraction was about 25–50ml. A Thermo Orion needle tip micro pH
electrode (Thermo Electron Corporation, Beverly, MA) was used to
measure the pH value of each fraction. Peptides from the FFE fractions
18–60 were puriﬁed on a C18 Sep-Pak cartridge (Waters Corporation,
Milford, MA, USA).
After puriﬁcation, the eluted peptides where split into three
fractions (one fraction was used for phosphopeptide isolation using
PAC, one for TiO2 and one for IMAC) and dried down and used for
phosphopeptide isolation.
Phosphopeptide isolation
The phosphopeptides were isolated using PAC, IMAC and TiO2 as
described by Bodenmiller et al (2007a, b).
MS analysis
Themajorityofsampleswere analyzedon ahybrid LTQ-Orbitrapmass
spectrometer(ThermoFischerScientiﬁc,Bremen,Germany)interfaced
with a nanoelectrospray ion source. Chromatographic separation of
peptides was achieved on an Eksigent nano LC system (Eksigent
Technologies, Dublin, CA, USA), equipped with a 11cm fused silica
emitter, 75mm inner diameter (BGB Analytik, Bo ¨ckten, Switzerland),
packed in-house with a Magic C18 AQ 3mm resin (Michrom
BioResources, Auburn, CA, USA). Peptides were loaded from a
cooled (41C) Spark Holland auto sampler and separated using ACN/
water solvent system containing 0.1% formic acid with a ﬂow rate
of 200nl/min. Peptide mixtures were separated with a gradient from
3 to 35% ACN in 90min.
Up to ﬁve data-dependent MS2 spectra were acquired in the linear
ion trap for each FT-MS spectral acquisition range, the latter acquired
at60000FWHMnominalresolutionsettingswithan overallcycletime
ofapproximately1s.Chargestatescreeningwasemployedtoselectfor
ions with two charges and rejecting ion with one or undetermined
charge state. The same sample was injected a second time with the
same setting besides the charge state screening, which was then set
to three and higher (excluding 1, 2 and undetermined charge state).
For injection control, the automaticgain control wasset to 5e5and 1e4
for full FTMS and linear ion trap MS2, respectively. The instrument
was calibrated externally according to manufacturers instructions.
The samples were acquired using internal lock mass calibration on
m/z 429.088735 and 445.120025.
For some pre-experiments and re-measurements, a hybrid LTQ-
FTICR mass spectrometer (Thermo, San Jose, CA) interfaced with
a nanoelectrospray ion source was used. Chromatographic separation
of peptides was achieved on an Agilent Series 1100 LC system
(Agilent Technologies,Waldbronn, Germany), equippedwith an 11cm
fused silica emitter, 150mm inner diameter (BGB Analytik, Bo ¨ckten,
Switzerland), packed in-house with a Magic C18 AQ 5mm resin
(Michrom BioResources, Auburn, CA, USA). Peptides were loaded
from a cooled (41C) Agilent auto sampler and separated with a linear
gradient of ACN/water, containing 0.15% formic acid, with a ﬂow rate
of 1.2ml/min. Peptide mixtures were separated with a gradient from 2
to 30% ACN in 90min. Three MS2 spectra were acquired in the linear
ion trap per each FT-MS scan, the latter acquired at 100000 FWHM
nominal resolution settings with an overall cycle time of approxi-
mately1s.Charge state screening was employed to select for ions with
atleasttwochargesandrejectingionswithundeterminedchargestate.
For each peptide sample, a standard data-dependent acquisition
method on the three most intense ions per MS-scan was used and a
threshold of 200 ion counts was used for triggering an MS2 attempt.
Data analysis
The MS2 data were searched against the FlyBase (Release 4.3)
(Grumbling and Strelets, 2006) nonredundant database containing
19465 proteins using SORCERER-SEQUEST(TM) v3.0.3, which was
run on the SageNSorcerer2 (ThermoElectron, San Jose, CA, USA). For
the in silico digest, trypsin was deﬁned as protease, cleaving after K
and R (if followed by P the cleavage was not allowed). Two missed
cleavages and one nontryptic terminus were allowed for the peptides
thathadamaximummassof6000Da.Theprecursoriontolerancewas
set to 5p.p.m. and the fragment ion tolerance was set to 0.8Da. Before
searching using Sequest, the neutral loss peaks were removed and
indicated as described previously (Bodenmiller et al, 2007b). Then
data were searched (for IMAC and TiO2) allowing phosphorylation
(þ79.9663Da) of serine, threonine and tyrosine as a variable modiﬁ-
cation and carboxyamidomethylation of cysteine (þ57.0214Da)
residues as a ﬁxed modiﬁcation. For PAC, in addition to the just
mentioned modiﬁcations, the methylation (þ14.0156Da) of all
carboxylate groups as a static modiﬁcation was also deﬁned. In the
end, the search results obtained by Sequest were subjected to
statistical ﬁltering using PeptideProphet (V3.0) (Keller et al, 2002)
and ProteinProphet(V3.0) (Keller et al, 2002). Proteins identiﬁed that
way were used for the analysis in Figure 1A and B. The proteins were
queried using the ‘panther classiﬁcation system’ (Mi et al, 2007)
http://www.pantherdb.org/ by using the batch search. FlyBase (r4.3)
was used as reference (Grumbling and Strelets, 2006) (0% depletion/
enrichment). Signiﬁcance of the biases was determined using a w
2 test.
If the same analysis is carried out using all proteins from
PhosphoPep (PeptideProphet P40.9; in the construction of Phospho-
Pep each peptide identiﬁed using PeptideProphet (with P40.8) was
mapped against each possible protein derived from the FlyBase
database (r4.3)) basically the same biases (with similar signiﬁcances)
as shown in Figure 1A and B were visible if queried using the ‘panther
classiﬁcation system’ (Mi et al, 2007) http://www.pantherdb.org/ by
using the batch search.
To determine the certainty of the assignment of a phosphate group
to a hydroxyamino acid, the dCn was used as it has been shown
recentlythatitdirectlycorrelateswiththecertaintyofphosphorylation
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consider a site well assigned (490% certainty), the following
assumption was made: as many of our phosphopeptides were
sequenced more than once, an uncertainty in the phosphorylation
site assignment will result in several ‘versions’ of a phosphopeptide,
namely that the amino-acid sequence is identical but that the site of
phosphorylation is different. After consolidation of the phosphopep-
tides using the computer program ‘Phosphogigolo’ (Bodenmiller et al,
2007b), we computed for a given dCn value the percentage of peptides
that have the same amino-acid sequence (ignoring the phosphate
group and the fact that a peptide can exist in two phosphorylation
states with a high certainty of phosphorylation site assignment).
Finally, the ‘percent’ ambiguous was computed by 2 (percentage of
redundant ‘stripped’ peptide entries) (Supplementary Figure S2).
Decoy database search strategy
The decoy database was designed in the following way: FlyBase
database (r4.3) was in silico digested using trypsin. Then the amino
acids of these peptides were scrambled except for the c-terminal lysine
orarginine.Proteinswerereconstructedbythescrambledpeptidesand
the label Rev_ was added to the protein names. This resulted in a
proteindatabasewithhalftheproteinsbeingoriginalandtheotherhalf
concatenated from the scrambled peptides. This decoy protein
database gives rise to peptides with approximately the same length
distribution as the original database. The false-positive rate was
estimated as described by Elias and Gygi (2007).
Creation of the consensus spectral library
ThePeptideProphet-processed SEQUESTsearch result fromall LC-MS/
MS runs performed on either a LTQ-Orbitrap or LTQ-FT mass
spectrometer was screened for spectra that are identiﬁed above a
probability threshold of 0.9 and a dCn value of 0.1. A total of over
170000conﬁdentlyidentiﬁedspectra mappingto about33000 distinct
peptide ions were collected. The spectra identiﬁed to the same peptide
ion (replicates) were then grouped, and collapsed into a single
consensus spectrum. The corresponding peaks in the replicates are
m/z-aligned, and only peaks that are present in a majority of the
replicates are included in the consensus, making no assumption about
the possible identities of the fragments. The consensus intensity of
each peak is calculated as the average of the peak intensities in the
replicates, weighted bya measure of the varying spectral quality of the
replicates. For peptide ions for which only a single observation is
made, the raw spectrum is included after simple noise reduction. All
theresultingspectraarethenannotatedandindexedforfastsearching.
The details of the consensus spectrum building algorithm, as well as
the software to perform it, will be provided in a future publication.
For the comparison of SpectraST and the Sequest database search
algorithmsin regards of search speed, twotest datasetswere used.For
the LTQ-Orbitrap, a randomly chosen data set with 10166 spectra and
for the LTQ data set randomly chosen 27556 spectra were used.
SpectraST was run on a single processor while SORCERER-SE-
QUEST(TM) v3.0.3, which was run on the SageN Sorcerer2. For the
database search, a 5p.p.m. parental mass tolerance was used for the
Orbitrap data set and 3Da for the LTQ data set.
The sensitivity and error curves were determined using the
PeptideProphet (Keller et al, 2002) (Supplementary Figure S3).
For the comparison of between SpectraSTand the Sequest database
search algorithms in regards of achieved sensitivity/identiﬁcations
threerandomlychosentestdatasetwereusedforeachIMAC,TiO2and
PAC. After database search (SpectraSTwas run on a single processor,
SORCERER-SEQUEST(TM)v3.0.3wasrunontheSageNSorcerer2)the
sensitivity and errorcurves were determined using the PeptideProphet
(Keller et al, 2002) (Supplementary Table I).
Determination of protein abundance based on
codon bias
Asdescribedpreviously(DuretandMouchiroud,1999)forallproteins,
the abundance, ranging from 1 (highly abundant) to 0 (very low
abundant), was calculated (Figure 1C).
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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